00000nam 2200000zi 4500 9.954007 CaOODSP 20250822145054 m o d f cr cn |||||||| 250812s2024 oncd obs f000 0 eng d CaOODSP eng rda CaOODSP eng fre n-cn--- H82-57/2024-PDF Zhang, Yvonne, author. Cost drivers for Canada's public and private drug plans during the COVID-19 pandemic : a 2019-2022 comparative analysis / Yvonne Zhang = Facteurs de coût des régimes d'assurance-médicaments publics et privés du Canada pendant la pandémie de COVID-19 : une analyse comparative 2019-2022 / Yvonne Zhang. Facteurs de coût des régimes d'assurance-médicaments publics et privés du Canada pendant la pandémie de COVID-19 : une analyse comparative 2019-2022 [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2024] 1 online resource (1 unnumbered page) : graphs text txt rdacontent computer c rdamedia online resource cr rdacarrier Caption title. "NPDUIS, National Prescription Drug Utilization Information System, "Supporting health care decision making in Canada" = SNIUMP, Le Système national d'information sur l'utilisation des médicaments prescrits, « Appuyer les décisions en matière des soins de santé au Canada »" Includes bibliographical references. "Canadian public drug plans and private insurers together account for over three quarters of all prescribed drug spending in Canada. This poster sheds light on the differences and similarities between key cost pressures for public and private drug plans, differentiating between short-term effects and those with longer-lasting impacts. The study spans from 2019, before the COVID-19 pandemic, to 2022, with a retrospective look at recent trends and highlights the impact of the pandemic on Canadian drug spending"--Introduction, page [1]. Text in English and French. Pharmaceutical policy Canada Statistics. Pharmaceutical services insurance Canada Costs Statistics. COVID-19 Pandemic, 2020-2023 Economic aspects Canada Statistics. Statistics lcgft Canada. Patented Medicine Prices Review Board, issuing body. Cost drivers for Canada's public and private drug plans during the COVID-19 pandemic : fre (CaOODSP)9.954006 PDF 538 KB https://publications.gc.ca/collections/collection_2025/cepmb-pmprb/H82-57-2024.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/cahspr2024-cost-drivers.html